Skip to main content
    Q

    Quanterix Corp (QTRX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.84
    -0.09 (-3.07%)

    Market Cap: $139.11M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Quanterix Corp (QTRX) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Quanterix (QTRX) is expected to report earnings on Jan 6, 2027. In the quarter ended Sep 30, 2026, Quanterix reported EPS of -$0.46, above the -$0.49 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    56%(20/36)
    Avg Surprise
    +1.19%
    Streak
    3 Q

    Upcoming Estimates

    Reports Jan 6, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.41
    Range-$0.44 - -$0.37
    5 analysts
    Revenue Consensus
    $39.67M
    Range$37.63M - $41.79M
    5 analysts
    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.48
    Range-$0.55 - -$0.40
    2 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.48
    Revenue Consensus
    $35.76M
    Range$34.00M - $37.20M
    3 analysts

    Next Report

    QTRX has an expected report date of Jan 6, 2027.

    QTRX Earnings Call

    The latest QTRX earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 36 quarters below that had an estimate, QTRX beat 20 and missed 16. Revenue for the quarter ended Sep 30, 2026 was $34.97M, down 13.1% from $40.23M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.46-$0.49N/A+6.12%BeatN/A31 up, 0 downNov 9, 2026$34.97M
    Jun 30, 2026-$0.45-$0.56N/A+19.64%BeatN/A30 up, 1 downAug 10, 2026$32.91M
    Mar 31, 2026$0.16-$0.62-$0.62 - -$0.62+125.81%BeatN/A10 up, 0 downMay 6, 2026$36.41M
    Dec 31, 2025-$0.47-$0.43-$0.67 - -$0.27-8.75%MissN/A31 up, 2 downMar 2, 2026$43.85M
    Sep 30, 2025-$0.73-$0.53-$0.71 - -$0.23-37.74%MissN/A31 up, 0 downNov 10, 2025$40.23M
    Jun 30, 2025-$0.47-$0.41N/A-14.63%MissN/AN/A0 up, 0 downAug 7, 2025$24.48M
    Mar 31, 2025-$0.53-$0.43N/A-23.26%MissN/AN/A0 up, 0 downMay 12, 2025$30.33M
    Dec 31, 2024-$0.30-$0.25-$0.26 - -$0.19-18.11%MissN/A60 up, 0 downMar 17, 2025$35.16M
    Sep 30, 2024-$0.22-$0.23-$0.30 - -$0.20+4.35%BeatN/A60 up, 0 downNov 11, 2024$35.81M
    Jun 30, 2024-$0.25-$0.26-$0.30 - -$0.21+3.85%BeatN/A60 up, 0 downAug 8, 2024$34.38M
    Mar 31, 2024-$0.26-$0.31-$0.36 - -$0.27+16.13%BeatN/A40 up, 0 downMay 7, 2024$32.07M
    Dec 31, 2023-$0.33-$0.32-$0.38 - -$0.28-3.13%MissN/A50 up, 0 downFeb 29, 2024$31.55M
    Sep 30, 2023-$0.21-$0.40-$0.40 - -$0.35+47.50%BeatN/A41 up, 1 downNov 6, 2023$31.56M
    Jun 30, 2023-$0.13-$0.41-$0.41 - -$0.35+68.29%BeatN/A41 up, 0 downAug 7, 2023$30.80M
    Mar 31, 2023-$0.14-$0.38-$0.40 - -$0.36+63.16%BeatN/A40 up, 0 downMay 9, 2023$28.46M
    Dec 31, 2022-$0.50-$0.47-$0.53 - -$0.38-6.38%MissN/A40 up, 0 downMar 6, 2023$25.82M
    Sep 30, 2022-$0.40-$0.44-$0.58 - -$0.24+9.09%BeatN/A41 up, 0 downNov 8, 2022$26.65M
    Jun 30, 2022-$0.67-$0.59-$0.67 - -$0.25-13.56%MissN/A40 up, 1 downAug 8, 2022$23.50M
    Mar 31, 2022-$0.49-$0.61-$0.67 - -$0.47+19.67%BeatN/A40 up, 0 downMay 10, 2022$29.55M
    Dec 31, 2021-$0.55-$0.66-$0.73 - -$0.55+16.67%BeatN/A6N/AMar 1, 2022$30.29M
    Sep 30, 2021-$0.43-$0.33-$0.42 - -$0.24-30.30%MissN/A62 up, 0 downNov 4, 2021$27.69M
    Jun 30, 2021-$0.31-$0.33-$0.37 - -$0.24+6.06%BeatN/A5N/AAug 5, 2021$25.37M
    Mar 31, 2021-$0.29-$0.34-$0.44 - -$0.28+14.71%BeatN/A5N/AMay 5, 2021$27.21M
    Dec 31, 2020-$0.31-$0.33-$0.43 - -$0.19+6.06%BeatN/A5N/AMar 2, 2021$26.13M
    Sep 30, 2020-$0.26-$0.42-$0.46 - -$0.39+38.10%BeatN/A5N/ANov 5, 2020$31.39M
    Jun 30, 2020-$0.41-$0.50-$0.53 - -$0.41+18.00%BeatN/A4N/AAug 4, 2020$13.13M
    Mar 31, 2020-$0.38-$0.41-$0.48 - -$0.31+7.32%BeatN/A5N/AMay 5, 2020$15.73M
    Dec 31, 2019-$0.39-$0.43-$0.55 - -$0.36+9.30%BeatN/A5N/AMar 13, 2020$15.92M
    Sep 30, 2019-$0.34-$0.44-$0.54 - -$0.36+22.73%BeatN/A5N/ANov 8, 2019$14.94M
    Jun 30, 2019-$0.46-$0.42-$0.48 - -$0.35-9.52%MissN/A5N/AAug 6, 2019$13.54M
    Mar 31, 2019-$0.42-$0.40-$0.47 - -$0.34-5.00%MissN/A5N/AMay 10, 2019$12.34M
    Dec 31, 2018-$0.39-$0.31-$0.38 - -$0.23-25.81%MissN/A5N/AMar 18, 2019$10.88M
    Sep 30, 2018-$0.35-$0.31N/A-12.90%MissN/AN/AN/ANov 7, 2018$10.59M
    Jun 30, 2018-$0.34-$0.29N/A-17.24%MissN/AN/AN/AAug 10, 2018$8.64M
    Mar 31, 2018-$0.33-$0.27N/A-22.22%MissN/AN/AN/AMay 15, 2018$7.52M
    Dec 31, 2017-$1.06-$0.32N/A-231.25%MissN/AN/AN/AMar 19, 2018$6.59M
    Sep 30, 2017-$0.75N/AN/AN/AN/AN/AN/AN/ADec 15, 2017$5.73M
    Jun 30, 2017-$0.37N/AN/AN/AN/AN/AN/AN/AJul 21, 2017$5.21M
    Last 38 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.20, after -$1.03 the year before. It was -$2.18 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.20N/A
    Dec 31, 2024-$1.03N/A
    Dec 31, 2023-$0.81N/A
    Dec 31, 2022-$2.06N/A
    Dec 31, 2021-$1.58N/A
    Dec 31, 2020-$1.36N/A
    Dec 31, 2019-$1.61N/A
    Dec 31, 2018-$1.41N/A
    Dec 31, 2017-$2.18N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,800 words across 8 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,8028
    2026Q2Jun 30, 20267,4838
    2026Q1Mar 31, 20264,4567
    2025Q4Dec 31, 20253,5697
    2025Q3Sep 30, 20255,0838
    2025Q2Jun 30, 20252,7156
    2025Q1Mar 31, 20256,6559
    2024Q4Dec 31, 20245,4509

    2026Q3 Earnings Call

    Opening remarks

    Mary Conway Investor Relations Thank you, and good morning. With me on today's call are Everett Cunningham, Quanterix's President and CEO, and Jason Faessler, Quanterix's Chief Financial Officer. Today's call is being recorded, and a replay of the call will be available on the Investors section of our website. During today's presentation, we will make forward-looking statements covered under the U.S. Private Securities Litigation Reform Act. These forward-looking statements are based on management's beliefs and assumptions as of today, November 9, 2026. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. To supplement our financial statements presented on a GAAP basis, we have provided certain non-GAAP financial measures. These non-GAAP measures are used to evaluate our operating performance in a manner that allows for meaningful period-to-period comparison and analysis of trends in our business and our competitors. We believe that such measures are important in comparing current results with other periods' results and assessing our operating performance within our industry. Non-GAAP financial information presented herein should be considered in conjunction with, and not as a substitute for, the financial information presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures set forth in the presentation posted to our website and in the earnings release issued today. Finally, any percentage changes we discuss will be on a year-over-year basis unless otherwise noted. Now I'd like to turn the call over to Everett Cunningham. Everett?

    Everett Cunningham President and CEO Thanks, Mary, and good morning, everybody. I'm happy to share that we exceeded our expectations for top-line performance in the third quarter, with sequential revenue growth of 6.3% and an improvement across the business. These results reflect the hard work of our entire team. Our solid Q3 results are an important early proof point in our path to restoring growth, and there's more. As shown on Slide 3, our commercial teams performed better across the board despite continued market softness, with strong sequential growth across all product categories and technology platforms. The Americas region posted the strongest improvement, with high-teens percentage growth. Spatial consumables were at a near-record level, demonstrating that our instrument installed base is being utilized. We're pleased with these first elements of recovery at Quanterix, which are reversing the revenue decline trend from last year.

    Frequently Asked Questions About QTRX

    When is Quanterix's next earnings date?

    Quanterix's next earnings report is expected for Jan 6, 2027.

    Did QTRX beat earnings estimates last quarter?

    Yes. Quanterix reported EPS of -$0.46 for the quarter ended Sep 30, 2026, above the -$0.49 estimate, a 6.12% surprise.

    What EPS do analysts expect from QTRX next quarter?

    The consensus EPS estimate for Quanterix for the quarter ending Dec 31, 2026 is -$0.41 from 5 analysts, with estimates from -$0.44 to -$0.37.

    How often does QTRX beat earnings estimates?

    Quanterix beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +6.14%.